Sarcoma: Concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

Annals of Oncology

Volumn 23, Issue 9, 2012, Pages 2442-2449

  Ray coquard, I ^a,b   Montesco, M C ^c   Coindre, J M ^d,e   Dei tos, A P ^f   Lurkin, A ^a,b   Ranchere vince D ^b   Vecchiato, A ^c   Decouvelaere, A V ^b   Mathoulin pelissier S ^d,e,g   Albert, S ^g   Cousin, P ^b   Cellier, D ^h   Toffolatti, L ^f   Rossi, C R ^c,i   Blay, J Y ^b  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE LÉON BÉRARD   (France)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e INSERM   (France)

^f General Hospital of Treviso   (Italy)

^g INSTITUT BERGONIÉ   (France)

^h Merck KGaA France   (France)

ⁱ UNIVERSITY OF PADOVA   (Italy)

Author keywords

Concordance evaluation; Histological review; Medical decision; Molecular biology; Sarcoma

Indexed keywords

ADOLESCENT; ADULT; ANGIOSARCOMA; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; ENDOMETRIUM SARCOMA; EWING SARCOMA; FEMALE; FIBROSARCOMA; FRANCE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ITALY; KAPOSI SARCOMA; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MYXOFIBROSARCOMA; PRIORITY JOURNAL; SARCOMA; SYNOVIAL SARCOMA; UTERUS MYOMA;

EID: 84864851590     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr610     Document Type: Article

References (32)

1. Colonna M, Hedelin G, Esteve J et al. National cancer prevalence estimation in France. Int J Cancer 2000; 87(2): 301-304.
2. Ducimetiere F, Lurkin A, Ranchere-Vince D et al. [Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhone-Alpes region]. Bull Cancer 2010; 97(6): 629-641.
3. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 2006; 48(1): 3-12.
4. Ray-Coquard I, Thiesse P, Ranchere-Vince D et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol 2004; 15: 307-315.
5. Pisters PW, Leung DH, Woodruff J et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14(5): 1679-1689.
6. Gustafson P, Dreinhofer KE, Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994; 65: 47-50.
7. Casali PG, Jost L, Sleijfer S et al. Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 (Suppl 2) ii89-ii93.
8. Arbiser ZK, Folpe AL, Weiss SW. Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol 2001; 116: 473-476.
9. Coindre JM, Nguyen BB, Goussot JF et al. [Histological changes after chemotherapy of soft tissue sarcomas in the adult]. Ann Pathol 1985; 5: 95-99.
10. Coindre JM, Tanguy F, Merlio JP et al. The value of immunohistological techniques in undifferentiated cancers. Tumori 1986; 72: 539-544.
11. Harris M, Hartley AL, Blair V et al. Sarcomas in north west England: I. Histopathological peer review. Br J Cancer 1991; 64: 315-320.
12. Katenkamp D. Cellular heterogeneity. Explanation for changing of tumor phenotype and biologic behavior in soft tissue sarcomas. Pathol Res Pract 1988; 183(6): 698-705.
13. Tomaszewski JE, Bear HD, Connally JA et al. Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol 2000; 114: 329-335.
14. Lind AC, Bewtra C, Healy JC et al. Prospective peer review in surgical pathology. Am J Clin Pathol 1995; 104: 560-566.
15. Kronz JD, Westra WH, Epstein JI. Mandatory second opinion surgical pathology at a large referral hospital. Cancer 1999; 86(11): 2426-2435.
16. Lurkin A, Ducimetiere F, Vince DR et al. Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region. BMC Cancer 2010; 10: 150.
17. Mastrangelo G, Fadda E, Cegolon L et al. A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health 2010; 10: 188.
18. Lapeyrere N, Parrens M, Coindre JM et al. [Impact of pathological review by an expert on the diagnosis and management of patients with cancer in Aquitania]. Ann Pathol 2008; 28: 478-485.
19. Guillou L, Coindre JM, Bonichon F et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-362.
20. Freycon F, Trombert-Paviot B, Casagranda L et al. Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer 2008; 50: 1213-1220.
21. Singer S, Corson JM, Demetri GD et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221: 185-195.
22. Ray-Coquard I, Chauvin F, Lurkin A et al. Medical practices and cancer care networks: examples in oncology. Bull Cancer 2006; 93: E13-E20.
23. Hassoun J, Bataillard A, Voigt JJ et al. [Standards, Options and Recommendations 2004: good practice guidelines for second opinion in anatomic and surgical pathology in oncology (integral report)]. Bull Cancer 2004; 91: 941-957.
24. Hasegawa T, Yamamoto S, Nojima T et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol 2002; 33: 111-115.
25. Lehnhardt M, Daigeler A, Hauser J et al. The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol 2008; 97: 40-43.
26. Bridge JA, Sandberg AA. Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol 2000; 29(5): 249-258.
27. Sandberg AA, Bridge JA. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet 2000; 123: 1-26.
28. Coindre JM, Trojani M, Contesso G et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986; 58: 306-309.
29. Meis-Kindblom JM, Bjerkehage B, Bohling T et al. Morphologic review of 1000 soft tissue sarcomas from the Scandinavian Sarcoma Group (SSG) Register. The peer-review committee experience. Acta Orthop Scand Suppl 1999; 285: 18-26.
30. Presant CA, Russell WO, Alexander RW et al. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol 1986; 4: 1658-1661.
31. Randall RL, Bruckner JD, Papenhausen MD et al. Errors in diagnosis and margin determination of soft-tissue sarcomas initially treated at non-tertiary centers. Orthopedics 2004; 27: 209-212.
32. LaCasce AS, Kho ME, Friedberg JW et al. Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol 2008; 26: 5107-5112.